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Abstract 
 
Perimenopausal syndrome occurs during the transition to menopause. Complementary and alternative medicine, 
especially Chinese medicinal plants, has manifested significant effects in alleviating perimenopausal symptoms. However, 
little research has been focused on the effects of Chinese medicinal plant on the immune function of the perimenopausal 
women. The present study aimed to explore the effects of Radix Astragali (RA) on the sex hormone levels and the 
interleukins of the ovariectomized female rats. 24 female Sprague-Dawley (SD) rats were randomly divided into model 
control group (MOD group), sham-operation group (SHAM group), RA group and estrogen group (EST group). After all the 
treatment ended, the serum levels of estradiol (E2), follicle stimulating hormone (FSH), luteinizing hormone (LH), 
interleukin-2 (IL-2), and interleukin-8 (IL-8) were measured using enzyme-linked immune-sorbent assay (ELISA) and the 
uterus was removed and weighed after blood exsanguinations immediately. In the MOD group, the serum levels of E2 were 
significantly lower, and the serum levels of FSH and LH were markedly higher than those of the RA group, EST group and 
SHAM group (P<0.05). In the RA group, the serum levels of E2 were significantly lower, and the serum levels of FSH were 
markedly higher than those of the SHAM group and EST group, respectively. In the MOD group, the serum levels of IL-2 
and IL-8 were significantly lower than those of the RA group, EST group and SHAM group (P<0.05), and no marked 
differences existed among RA group, EST group and SHAM group in the serum levels of IL-2 and IL-8 (P>0.05). The 
uterine weight of the rats in the RA group, EST group and SHAM group were significantly higher than those of the rats in 
MOD group (P<0.05). There were no marked differences among the rats from RA group, EST group and SHAM group on 
the uterine weight (P>0.05). It is concluded that RA can significantly improve the immune functions of the ovariectomized 
female rats, although it cannot change the sex hormones levels as significantly as estrogen. 
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Introduction 
 
As we know, perimenopausal syndrome occurs during the transition to menopause, which is often accompanied by hot 
flashes and degenerative processes such as arteriosclerosis and atrophic changes of the skin and these symptoms suggest an 
acceleration of aging triggered by estrogen lack (Miquel et al., 2006). Hormone replacement therapy (HRT) has been 
considered as the most suitable treatment for the above symptoms and processes (Roberts, 2012). However, some previous 
clinical trials using different estrogen formulations, doses of raloxifene combined with estrogens failed to show the certified 
effects of HRT on the quality of life in the menopausal women (Carneiro et al., 2012). HRT is even contraindicated for the 
women with a history of breast cancer (Duijts et al., 2009). Complementary and alternative medicine, especially Chinese 
medicinal plants, have manifested significant effects in alleviating perimenopausal symptoms (Borrelli and Ernst, 2010; 
Kessel and Kronenberg, 2004; Kronenberg and Fugh-Berman, 2002; Lloyd and Hornsby, 2009; Seidl and Stewart, 1998; 
Shou et al., 2011).  
As we know, cytokines are biologically active macromolecules of protein structure (Martin et al., 2006), and HRT was 
found to improve the balance of Th1/Th2 cytokines mainly through estrogen acting in T lymphocytes (Xia et al., 2009). The 
perimenopausal women present a totally different alteration in serum cytokine profile of interleukins from the fertile women 
(Cioffi et al., 2002). In a study to explore the effects of HRT on T-cell function in postmenopausal women, the researchers 
found that HRT improved the aberration of Th1/Th2 balance that is implicated in an inadequate immune response and 
pathological conditions (Kamada et al., 2001). However, little research has been focused on the effects of Chinese medicinal 
plant on the immune function of the perimenopausal women. Radix Astragali (RA Chinese name: Huang Qi, family:), it is the 
root portion of Astragalus membranaceus or Astragalus propinquus, belonging to the legume family Fabaceae, subfamily 
Faboideae. RA is one the most commonly used medicinal plants involved in the female reproductive system (Mazaro-Costa 
et al., 2010). RA has been reported to have eminently positive effects on the immune system (WHO). The present study 
aimed to explore the effects of RA on the sex hormone levels and the interleukins of the ovariectomized female rats.  
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Materials and methods 
Animals 
 
32 ten-week-old female Sprague-Dawley (SD) rats (weighing 220±20g) were provided by the Laboratory Animal Center of 
Zhejiang Chinese Medicine University (Hangzhou, China). The animals were kept in a room under a 12h light–12h dark 
cycle and environmentally controlled conditions of 22±2°C. All the animals were acclimatized one week before the 
experiment. The research was carried out according to the National Research Council's protocol for the care and use of 
laboratory animals. Eight rats were randomly taken as the sham-operation group (SHAM group) and the other 24 rats were 
bilaterally ovariectomized as described by EI-Bakri et al (El-Bakri et al., 2004). All of the 32 rats were anesthetized with an 
intraperitoneal (i.p.) injection of sodium pentobarbital (50 mg/kg). The vaginal smear was taken from each of the 32 rats once 
daily for 4 consecutive days from the 3rd day after the ovariectomized operation. Six rats with classic estrous cycles in the 
SHAM group were included in the study. The successfully ovariectomized rats, confirmed by predominantly leukocytes with 
few epithelial cells in vaginal smears over at least 4 days, were randomly divided into RA group, estrogen group (EST group), 
and model control group (MOD group) (n=6 in each group).  
 
The preparation of plant materials  
 
RA was provided and identified by Zhejiang Chinese Medicine University (Hangzhou, China). RA was extracted by refluxing 
per 25g with 250ml of water for 60 min followed by filtration. The same extraction procedures were repeated once. The 
obtained solution was combined and condensed to a concentration of 1g/ml, which was then freeze dried and get extract of 
RA. 
 
Group and administration 
 
The rats in RA group were orally administrated the extracts of RA at 71 mg/kg once daily for 28 consecutive days. The rats in 
EST group were orally administrated estradiol valerate tablet (provide by Bayer AG, Germany) at 1.2 mg/kg once daily for 28 
consecutive days. The rats in MOD group and SHAM group were orally administrated saline at 8ml/kg once daily for 28 
consecutive days. On the day following the final administration, the serum and uterus samples were taken after the rats were 
anesthetized with diethyl ether. The serum obtained was stored at −80 ◦C until assay. The serum levels of estradiol (E2), 
follicle stimulating hormone (FSH), luteinizing hormone (LH), interleukin-2 (IL-2), and interleukin-8 (IL-8) were measured 
using enzyme-linked immune-sorbent assay (ELISA, R&D Systems, MN, USA). All the measurements were carried out in 
duplicate and were conducted according to the manufacturer’s instruction. The uterus was also removed and weighed after 
blood exsanguinations immediately.  
 
Statistical analysis 
 
Results were analyzed with Statistical Package for Social Sciences (SPSS 13.0 for Windows). Analysis of variance (ANOVA) 
was employed for analyzing all the data. A 5% significance level (P<0.05) and two-tailed tests were used for all hypothesis 
tests. 
 
 
 
Results 
Comparison of the serum levels of E2, FSH and LH 
 
In the MOD group, the serum levels of E2 were significantly lower, and the serum levels of FSH and LH were markedly 
higher than those of the RA group, EST group and SHAM group (P<0.05), which were shown as Figure 1. As shown in 
Figure 1A and 1B, in the RA group, the serum levels of E2 were significantly lower, and the serum levels of FSH were 
markedly higher than those of the SHAM group and EST group, respectively (P<0.05). There were no significant differences 
among RA group, EST group and SHAM group on the serum LH levels (P>0.05). 
 
Comparison of the serum levels of IL-2 and IL-8 
 
As shown in Figure 2, in the MOD group, the serum levels of IL-2 and IL-8 were significantly lower than those of the RA 
group, EST group and SHAM group (P<0.05), and no marked differences existed among RA group, EST group and SHAM 
group in the serum levels of IL-2 and IL-8 (P>0.05). 
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Figure 1: The serum levels of sex hormones. (A) The serum levels of estradiol (E2) of model control (MOD) group, 
sham-operation (SHAM) group, estrogen (EST) group and Radix Astragali (RA) group. (B) The serum levels of 
follicle stimulating hormone (FSH) of all the four groups. (C) The serum levels of luteinizing hormone (LH) of all 
the four groups. Data were shown as mean ± SD. (n=6 in each group). The significant difference was set at a P<0.05, 
compared with the MOD group; b p <0.05, compared with the SHAM group; c P<0.05, compared with the EST 
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group. 
 
 
 
 
Figure. 2: The serum levels of interleukins (A) The serum levels of interleukin-2 (IL-2) of the four groups. (B) The serum 
levels of interleukin-8 (IL-8) of the four groups. Data were shown as mean ± SD. (n=6 in each group). The 
significant difference was set at a P<0.05, compared with the MOD group; b p <0.05, compared with the SHAM 
group; c P<0.05, compared with the EST group. 
 
 
Comparison of the uterine wet weight 
 
As shown in Figure 3, the uterine weight of the rats in the RA group, EST group and SHAM group were significantly higher 
than those of the rats in MOD group (P<0.05). There were no marked differences among the rats from RA group, EST group 
and SHAM group on the uterine wet weight (P>0.05). 
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Figure 3: Comparison of the uterine weight. Data were shown as mean ± SD. (n=6 in each group). The significant difference 
was set at a P<0.05, compared with the MOD group; b p <0.05, compared with the SHAM group; c P<0.05, 
compared with the EST group. 
 
 
 
 
Discussion 
 
Estrogen has been found to have both cognitive functions and neurobiological protective effects particularly when therapy is 
initiated close to the time of menopause before neural systems become increasingly compromised (Voytko et al., 2009). 
However, due to recent clinical trial negative results on hormone therapy, many postmenopausal women question whether to 
start or continue hormone therapy. Meanwhile, the market for complementary and alternative therapies for HRT has 
dramatically increased (Noguchi et al., 2009; Shou et al., 2011; Yeh and Chang, 2012). Women are seeking more natural 
alternatives to treat menopausal symptoms worldwide. We found in the present study that RA can improve the serum levels 
of IL-2 and IL-8 of the ovariectomized female rats as significantly as EST, although it did not alter the serum levels of E2, 
FSH and LH. 
In recent years, more and more studies have focused on effects of HRT on the levels of immunoregulatory cytokines. A 
clinical investigation on previously healthy women who had undergone a total hysterectomy and bilateral 
salpingo-oopherectomy aiming to explore the effect of oral and transdermal estrogen replacement therapy on the expression 
of different estrogen receptor subtypes and the secretion of immunoregulatory cytokines found both oral and transdermal 
HRT can improve the balance of Th1/Th2 cytokines (Xia et al., 2009). Postmenopausal women without HRT were found to 
experience greater muscle damage, indicating a possible protective effect of HRT against exercise-induced skeletal muscle 
damage, during which mRNA expression of IL-6, IL-8 and IL-15 changed markedly in the control group compared with the 
HRT group (Dieli-Conwright et al., 2009). In a clinical trial to investigate the effects of HRT on immune function in 
menopausal women the researchers found significant alterations on the interleukin levels (Saucedo et al., 2002). 
Estrogen/progesterone HRT has been demonstrated to affect cell-mediated immunity, thus being a potential factor 
influencing development and course of autoimmune disorders and neoplastic diseases (Stopinska-Gluszak et al., 2006). 
Although RA did not change the sex hormones levels as significantly as estrogen did, we found RA can significantly improve 
the immune functions of the ovariectomized female rats, which merits further study. More study will be conducted on the 
effects of RA on the behavior of the ovariectomized female rats in the near future.  
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